Literature DB >> 22541946

Protracted withdrawal from cocaine self-administration flips the switch on 5-HT(1B) receptor modulation of cocaine abuse-related behaviors.

Nathan S Pentkowski1, Tim H C Cheung, William A Toy, Matthew D Adams, John F Neumaier, Janet L Neisewander.   

Abstract

BACKGROUND: The role of serotonin-1B receptors (5-HT(1B)Rs) in modulating cocaine abuse-related behaviors has been controversial due to discrepancies between pharmacological and gene knockout approaches and opposite influences on cocaine self-administration versus cocaine-seeking behavior. We hypothesized that modulation of these behaviors via 5-HT(1B)Rs in the mesolimbic pathway may vary depending on the stage of the addiction cycle.
METHODS: To test this hypothesis, we examined the effects of increasing 5-HT(1B)R production by microinfusing a viral vector expressing either green fluorescent protein and 5-HT(1B)R or green fluorescent protein alone into the medial nucleus accumbens shell of rats either during maintenance of cocaine self-administration (i.e., active drug use) or during protracted withdrawal.
RESULTS: 5-HT(1B)R receptor gene transfer during maintenance shifted the dose-response curve for cocaine self-administration upward and to the left and increased breakpoints and cocaine intake on a progressive ratio schedule, consistent with enhanced reinforcing effects of cocaine. In contrast, following 21 days of forced abstinence, 5-HT(1B)R gene transfer attenuated breakpoints and cocaine intake on a progressive ratio schedule of reinforcement, as well as cue- and cocaine-primed reinstatement of cocaine-seeking behavior.
CONCLUSIONS: This unique pattern of effects suggests that mesolimbic 5-HT(1B)Rs differentially modulate cocaine abuse-related behaviors, with a facilitative influence during periods of active drug use, in striking contrast to an inhibitory influence during protracted withdrawal. These findings suggest that targeting 5-HT(1B)Rs may lead to a novel treatment for cocaine dependence and that the therapeutic efficacy of these treatments may vary depending on the stage of the addiction cycle.
Copyright © 2012 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22541946      PMCID: PMC4071622          DOI: 10.1016/j.biopsych.2012.03.024

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  59 in total

1.  The effect of serotonin 5HT1B receptor ligands on amphetamine self-administration in rats.

Authors:  Joanna Miszkiel; Przemysław Adamczyk; Małgorzata Filip; Edmund Przegaliński
Journal:  Eur J Pharmacol       Date:  2011-12-29       Impact factor: 4.432

Review 2.  Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy.

Authors:  N R Richardson; D C Roberts
Journal:  J Neurosci Methods       Date:  1996-05       Impact factor: 2.390

3.  Cocaine increases 5-HT1B mRNA in rat nucleus accumbens shell neurons.

Authors:  B J Hoplight; E S Vincow; J F Neumaier
Journal:  Neuropharmacology       Date:  2006-10-23       Impact factor: 5.250

4.  Increased vulnerability to cocaine in mice lacking the serotonin-1B receptor.

Authors:  B A Rocha; K Scearce-Levie; J J Lucas; N Hiroi; N Castanon; J C Crabbe; E J Nestler; R Hen
Journal:  Nature       Date:  1998-05-14       Impact factor: 49.962

5.  Manipulation of operant responding for an ethanol-paired conditioned stimulus in the rat by pharmacological alteration of the serotonergic system.

Authors:  A W Wilson; B Costall; J C Neill
Journal:  J Psychopharmacol       Date:  2000       Impact factor: 4.153

Review 6.  Herpes simplex virus-mediated gene transfer as a tool for neuropsychiatric research.

Authors:  W A Carlezon; E J Nestler; R L Neve
Journal:  Crit Rev Neurobiol       Date:  2000

7.  Pretreatment with the dopamine agonist 7-OH-DPAT shifts the cocaine self-administration dose-effect function to the left under different schedules in the rat.

Authors:  S.B. Caine; G.F. Koob
Journal:  Behav Pharmacol       Date:  1995-06       Impact factor: 2.293

8.  Glutamatergic and nonglutamatergic neurons of the ventral tegmental area establish local synaptic contacts with dopaminergic and nondopaminergic neurons.

Authors:  Alice Dobi; Elyssa B Margolis; Hui-Ling Wang; Brandon K Harvey; Marisela Morales
Journal:  J Neurosci       Date:  2010-01-06       Impact factor: 6.167

9.  Serotonin1B receptors in the ventral tegmental area modulate cocaine-induced increases in nucleus accumbens dopamine levels.

Authors:  L E O'Dell; L H Parsons
Journal:  J Pharmacol Exp Ther       Date:  2004-06-28       Impact factor: 4.030

Review 10.  New developments in the pharmacotherapy of cocaine abuse.

Authors:  Antonio Preti
Journal:  Addict Biol       Date:  2007-06       Impact factor: 4.280

View more
  19 in total

1.  Differential effect of viral overexpression of nucleus accumbens shell 5-HT1B receptors on stress- and cocaine priming-induced reinstatement of cocaine seeking.

Authors:  Sunila G Nair; Amy R Furay; Yusha Liu; John F Neumaier
Journal:  Pharmacol Biochem Behav       Date:  2013-09-25       Impact factor: 3.533

Review 2.  Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction.

Authors:  Kathryn A Cunningham; Noelle C Anastasio
Journal:  Neuropharmacology       Date:  2013-07-11       Impact factor: 5.250

3.  The 5-HT1B serotonin receptor regulates methylphenidate-induced gene expression in the striatum: Differential effects on immediate-early genes.

Authors:  David Alter; Joel A Beverley; Ronak Patel; Carlos A Bolaños-Guzmán; Heinz Steiner
Journal:  J Psychopharmacol       Date:  2017-07-18       Impact factor: 4.153

4.  Reductions in brain 5-HT1B receptor availability in primarily cocaine-dependent humans.

Authors:  David Matuskey; Zubin Bhagwagar; Beata Planeta; Brian Pittman; Jean-Dominique Gallezot; Jason Chen; Jane Wanyiri; Soheila Najafzadeh; Jim Ropchan; Paul Geha; Yiyun Huang; Marc N Potenza; Alexander Neumeister; Richard E Carson; Robert T Malison
Journal:  Biol Psychiatry       Date:  2013-11-28       Impact factor: 13.382

5.  Associations of the 5-hydroxytryptamine (serotonin) receptor 1B gene (HTR1B) with alcohol, cocaine, and heroin abuse.

Authors:  Jian Cao; Emily LaRocque; Dawei Li
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2013-01-17       Impact factor: 3.568

6.  Fluoxetine potentiation of methylphenidate-induced gene regulation in striatal output pathways: potential role for 5-HT1B receptor.

Authors:  Vincent Van Waes; Sarah Ehrlich; Joel A Beverley; Heinz Steiner
Journal:  Neuropharmacology       Date:  2014-09-16       Impact factor: 5.250

7.  Restoration of Kv7 Channel-Mediated Inhibition Reduces Cued-Reinstatement of Cocaine Seeking.

Authors:  Jeffrey Parrilla-Carrero; William C Buchta; Priyodarshan Goswamee; Oliver Culver; Greer McKendrick; Benjamin Harlan; Aubin Moutal; Rachel Penrod; Abigail Lauer; Viswanathan Ramakrishnan; Rajesh Khanna; Peter Kalivas; Arthur C Riegel
Journal:  J Neurosci       Date:  2018-04-10       Impact factor: 6.167

8.  Depression-like symptoms of withdrawal in a genetic mouse model of binge methamphetamine intake.

Authors:  Shkelzen Shabani; Bryan Schmidt; Bikalpa Ghimire; Sydney K Houlton; Laura Hellmuth; Erika Mojica; Tamara J Phillips
Journal:  Genes Brain Behav       Date:  2018-11-26       Impact factor: 3.449

Review 9.  Dopamine D3 and 5-HT1B receptor dysregulation as a result of psychostimulant intake and forced abstinence: Implications for medications development.

Authors:  Janet L Neisewander; Timothy H C Cheung; Nathan S Pentkowski
Journal:  Neuropharmacology       Date:  2013-08-23       Impact factor: 5.250

10.  Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms.

Authors:  Petra Amchova; Jana Kucerova; Valentina Giugliano; Zuzana Babinska; Mary T Zanda; Maria Scherma; Ladislav Dusek; Paola Fadda; Vincenzo Micale; Alexandra Sulcova; Walter Fratta; Liana Fattore
Journal:  Front Pharmacol       Date:  2014-03-20       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.